Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
2014926 citationsSteven D. Schwartz, Carl D. Regillo et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Eddy Anglade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddy Anglade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddy Anglade more than expected).
This network shows the impact of papers produced by Eddy Anglade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddy Anglade. The network helps show where Eddy Anglade may publish in the future.
Co-authorship network of co-authors of Eddy Anglade
This figure shows the co-authorship network connecting the top 25 collaborators of Eddy Anglade.
A scholar is included among the top collaborators of Eddy Anglade based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Eddy Anglade. Eddy Anglade is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
17 of 17 papers shown
1.
Schwartz, Steven D., Carl D. Regillo, Byron L. Lam, et al.. (2018). Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data. Investigative Ophthalmology & Visual Science. 59(9). 5004–5004.2 indexed citations
Schwartz, Steven D., Carl D. Regillo, Byron L. Lam, et al.. (2014). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. The Lancet. 385(9967). 509–516.926 indexed citations breakdown →
4.
Gilger, Brian C., et al.. (2010). A Clear, Mixed Nanomicellar Formulation of Voclosporin (LX214), Achieves Therapeutic Levels in Ocular Posterior Segment After Single and Multiple Topical Dosing in Rabbits. 51(13). 5323–5323.1 indexed citations
5.
Kohn, Joachim, et al.. (2010). Ocular Biocompatibility, Toxicity, and Distribution From Erodible Polycarbonate Polymer Episcleral Implants (LX212) in Rabbits. 51(13). 5326–5326.1 indexed citations
Gilger, Brian C., et al.. (2008). Preclinical Acute Toxicity and Pharmacokinetics of Episcleral LX201 Implants in Rabbits. 49(13). 1964–1964.3 indexed citations
Sullivan, Daniel M., Daniel C. Chung, Eddy Anglade, Robert B. Nussenblatt, & Karl G. Csaky. (1996). Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium.. PubMed. 37(5). 766–74.18 indexed citations
Gery, Igal, et al.. (1994). Recoverin is highly uveitogenic in Lewis rats.. PubMed. 35(8). 3342–5.78 indexed citations
17.
Anglade, Eddy, Craig A. McKeown, & Richard M. Robb. (1992). Brown??s Syndrome. International Ophthalmology Clinics. 32(1). 63–70.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.